Spondylarthritis: all 600 studies

Page 2 of 6. Open to participants first (92), then studies with results posted, then the rest; newest registration first within each.

• MRE as a Screening Tool for axSpA in IBDCompletedNCT03817983Results posted
• A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic ArthritisCompletedNCT03733925Phase 4Results posted
• Efficacy and Safety of Namilumab for Moderate-to-severe Axial SpondyloarthritisCompletedNCT03622658Phase 2Results posted
• Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated With GolimumabCompletedNCT03557853Results posted
• Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)CompletedNCT03502616Phase 3Results posted
• Non-Steroidal Anti-inflammatory Drugs in Axial SpondyloarthritisTerminatedNCT03473665Phase 4Results posted
• Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's DiseaseCompletedNCT03357471Phase 3Results posted
• A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing SpondylitisCompletedNCT03355573Phase 2Results posted
• Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing SpondylitisCompletedNCT03350815Phase 4Results posted
• Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut InflammationCompletedNCT03270501Phase 3Results posted
• Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar)CompletedNCT03259074Phase 3Results posted
• A Post-Marketing-Observational Study (PMOS) to Determine the Effectiveness of Combined Adalimumab Treatment and Active Supervised Training in Patients With Axial Spondyloarthritis (axSpA)TerminatedNCT03258814Results posted
• Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038)CompletedNCT03253796Phase 4Results posted
• 99mTc-rhAnnexin V-128 in Diagnosis of SpondyloarthritisTerminatedNCT03232580Phase 2Results posted
• A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing SpondylitisCompletedNCT03215277Phase 2Results posted
• SKIPPAIN - Speed of Onset of SecuKinumab-Induced Relief From Pain in Patients With AxIal SpoNdyloarthritisCompletedNCT03136861Phase 3Results posted
• A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial SpondyloarthritisCompletedNCT03129100Phase 3Results posted
• Custom Pack in Spine SurgeryCompletedNCT03050203Not applicableResults posted
• PREDICT-SpA - French Epidemiological Study of the Evaluation of the Impact of Fibromyalgia in the TNF Alpha Treatment Effect in Axial Spondyloarthritis in Both Anti-TNF naïve and - Experienced PatientsCompletedNCT03039088Results posted
• Efficacy and Safety Study of SUNPG1622TerminatedNCT02980705Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing SpondylitisCompletedNCT02963506Phase 2Results posted
• A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine TreatmentTerminatedNCT02897115Phase 4Results posted
• Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing SpondylitisCompletedNCT02896127Phase 3Results posted
• Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon SiteCompletedNCT02771210Phase 3Results posted
• Study to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing SpondylitisCompletedNCT02763046Phase 4Results posted
• A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial SpondyloarthritisCompletedNCT02757352Phase 3Results posted
• Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)CompletedNCT02750800Results posted
• Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing SpondylitisCompletedNCT02750592Phase 3Results posted
• Imaging Biomarkers in Crohn's Associated SpondyloarthritisCompletedNCT02709694Results posted
• A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial SpondyloarthritisCompletedNCT02696798Phase 3Results posted
• A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial SpondyloarthritisCompletedNCT02696785Phase 3Results posted
• Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial SpondyloarthritisCompletedNCT02696031Phase 3Results posted
• An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing SpondylitisTerminatedNCT02557308Results posted
• Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of ASCompletedNCT02552212Phase 3Results posted
• Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to PlaceboCompletedNCT02505542Phase 3Results posted
• A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.CompletedNCT02486302Results posted
• A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial SpondyloarthritisTerminatedNCT02438787Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial SpondyloarthritisTerminatedNCT02437162Phase 3Results posted
• An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial SpondyloarthritisTerminatedNCT02407223Phase 3Results posted
• Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing SpondylitisCompletedNCT02359903Phase 1Results posted
• Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) PatientsCompletedNCT02333383Results posted
• 99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS)TerminatedNCT02328027Phase 1/2Results posted
• Defining Remission With Etanercept in AS in Real Life Clinical PracticeCompletedNCT02202850Results posted
• 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing SpondylitisCompletedNCT02159053Phase 3Results posted
• A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating MothersCompletedNCT02154425Phase 1Results posted
• BI 655066 (Risankizumab) Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS)CompletedNCT02047110Phase 2Results posted
• A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the PlacentaCompletedNCT02019602Phase 1Results posted
• Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial SpondyloarthritisCompletedNCT02011386Results posted
• 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis PatientsCompletedNCT02008916Phase 3Results posted
• Extension in AS: Sustainability of Benefits, Safety and TolerabilityCompletedNCT01863732Phase 3Results posted
• Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in ItalyCompletedNCT01856569Results posted
• Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in BelgiumCompletedNCT01845818Results posted
• Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial SpondyloarthritisCompletedNCT01808118Phase 3Results posted
• Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing SpondylitisCompletedNCT01786668Phase 2Results posted
• Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical PracticeCompletedNCT01768858Results posted
• Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical PracticeCompletedNCT01754727Results posted
• Exercise Therapy Program in Ankylosing Spondylitis PatientsCompletedNCT01690273Not applicableResults posted
• The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012)CompletedNCT01668004Phase 4Results posted
• 16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing SpondylitisCompletedNCT01649375Phase 3Results posted
• Study of Apremilast to Treat Subjects With Active Ankylosing SpondylitisCompletedNCT01583374Phase 3Results posted
• Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic ArthritisCompletedNCT01474876Results posted
• Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006)CompletedNCT01453725Phase 3Results posted
• Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.CompletedNCT01421303Results posted
• Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing SpondylitisCompletedNCT01417455Results posted
• A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient DepartmentTerminatedNCT01411215Results posted
• 16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing SpondylitisCompletedNCT01358175Phase 3Results posted
• Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)CompletedNCT01329380Results posted
• A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)CompletedNCT01313858Results posted
• A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial SpondyloarthritisCompletedNCT01298531Phase 4Results posted
• Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With AdalimumabCompletedNCT01282372Results posted
• Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With AdalimumabCompletedNCT01273519Results posted
• Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural ChangesCompletedNCT01258738Phase 3Results posted
• Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing SpondylitisCompletedNCT01248793Phase 3Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDsTerminatedNCT01209702Phase 3Results posted
• A Study of Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist TherapyTerminatedNCT01209689Phase 3Results posted
• A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108)CompletedNCT01208207Phase 3Results posted
• Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing SpondylitisCompletedNCT01188655Results posted
• Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal HealingCompletedNCT01174186Phase 4Results posted
• Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical CareCompletedNCT01163916Results posted
• Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing SpondylitisTerminatedNCT01118728Phase 2Results posted
• Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing SpondylitisCompletedNCT01114880Phase 3Results posted
• Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing SpondylitisCompletedNCT01109940Phase 2Results posted
• Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDsCompletedNCT01091675Phase 3Results posted
• Certolizumab Pegol in Subjects With Active Axial SpondyloarthritisCompletedNCT01087762Phase 3Results posted
• Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic DrugsCompletedNCT01083693Results posted
• Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS)CompletedNCT01079182Results posted
• A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )CompletedNCT01078558Results posted
• EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European CountriesCompletedNCT01078402Results posted
• Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA)CompletedNCT01064856Phase 3Results posted
• Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing SpondylitisCompletedNCT01061723Phase 2Results posted
• Spondylitis Trial of Apremilast for Better Rheumatic TherapyCompletedNCT00944658Phase 2Results posted
• Study of Adalimumab in Patients With Axial SpondyloarthritisCompletedNCT00939003Phase 3Results posted
• Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis PatientsTerminatedNCT00910273Phase 4Results posted
• Study Evaluating Predictors of Response in Patients With Ankylosing SpondylitisCompletedNCT00900796Results posted
• Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in SpainCompletedNCT00873730Phase 4Results posted
• Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)CompletedNCT00844805Phase 3Results posted
• Remicade Safety Line (Ankylosing Spondylitis)(Study P03275)(COMPLETED)CompletedNCT00818168Results posted
• Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing SpondylitisCompletedNCT00809159Phase 2Results posted
• Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED)CompletedNCT00778869Phase 4Results posted
• Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing SpondylitisCompletedNCT00762463Phase 3Results posted

← Spondylarthritis overview